US Stock MarketDetailed Quotes

ADAP Adaptimmune Therapeutics

Watchlist
  • 1.584
  • +0.004+0.27%
Trading Mar 28 12:41 ET
391.04MMarket Cap-2933P/E (TTM)

About Adaptimmune Therapeutics Company

Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.

Company Profile

SymbolADAP
Company NameAdaptimmune Therapeutics
Listing Date05/06/2015
Issue Price17.00
Founded2008
CEOMr. Adrian Rawcliffe
MarketNASDAQ
Employees449
Securities TypeDR
ADS Ratio1.0 : 6.0
Fiscal Year Ends12-31
Address60 Jubilee Avenue,Milton Park
CityAbingdon
ProvinceOxfordshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeOX14 4RX
Phone44-1235-430000

Company Executives

  • Name
  • Position
  • Salary
  • Adrian Rawcliffe
  • Director and Chief Executive Officer
  • 3.41M
  • William C. Bertrand, Jr
  • Chief Operating Officer
  • 1.39M
  • Gavin Hilary James Wood
  • Chief Financial Officer and Principal Accounting Officer
  • 1.32M
  • Dr. Helen Tayton-Martin, PhD
  • Chief Business and Strategy Officer
  • 1.37M
  • John Lunger
  • Chief Patient Supply Officer
  • 932.61K
  • Dr. Elliot Norry
  • Chief Medical Officer
  • 1.77M
  • Dr. Joanna Brewer
  • Chief Scientific Officer
  • --
  • Cintia Piccina
  • Chief Commercial Officer
  • 2.19M
  • Michael Garone
  • Principal Accounting Officer
  • 217.00K
  • David M. Mott
  • Chairman of the Board
  • 208.54K
  • Dr. Andrew R. Allen, M.D.,PhD
  • Independent Director
  • --
  • Dr. Kristen M. Hege, M.D.
  • Independent Director
  • --
  • Lawrence M. Alleva
  • Independent Director
  • 170.11K
  • Dr. Garry E. Menzel, PhD
  • Independent Director
  • --
  • Dr. Ali Behbahani, M.B.A.,M.D.
  • Independent Director
  • 153.64K
  • John P. Furey
  • Independent Director
  • 161.73K
  • Dr. Priti Hegde, PhD
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg